• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.新型隐球菌的氟康唑药敏试验:两种肉汤微量稀释法的比较及乌干达艾滋病患者分离株的临床相关性
J Clin Microbiol. 1998 Oct;36(10):2874-6. doi: 10.1128/JCM.36.10.2874-2876.1998.
2
Susceptibility testing of Cryptococcus neoformans: a microdilution technique.新型隐球菌药敏试验:一种微量稀释技术。
J Clin Microbiol. 1992 Nov;30(11):2881-6. doi: 10.1128/jcm.30.11.2881-2886.1992.
3
Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole.新型隐球菌对氟康唑药敏试验肉汤微量稀释法的多中心评估
J Clin Microbiol. 1996 May;34(5):1280-2. doi: 10.1128/jcm.34.5.1280-1282.1996.
4
Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole.新型隐球菌对氟康唑的肉汤稀释法、肉汤微量稀释法和E试验药敏试验的比较。
Mycoses. 1997 Dec;40(11-12):423-7. doi: 10.1111/j.1439-0507.1997.tb00179.x.
5
In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.新型隐球菌分离株对氟康唑和伊曲康唑的体外敏感性
J Antimicrob Chemother. 1998 Aug;42(2):217-20. doi: 10.1093/jac/42.2.217.
6
Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans.培养基对新型隐球菌生长速率及药敏试验的影响
Mycoses. 1996 May-Jun;39(5-6):201-6. doi: 10.1111/j.1439-0507.1996.tb00125.x.
7
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.采用各种抗真菌药敏试验方法所获得的结果并不能预测隐球菌病患者的早期临床结局。
Antimicrob Agents Chemother. 2006 Jul;50(7):2464-70. doi: 10.1128/AAC.01520-05.
8
Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.氟康唑最低抑菌浓度与隐球菌感染临床结局的相关性。
Antimicrob Agents Chemother. 2000 Jun;44(6):1544-8. doi: 10.1128/AAC.44.6.1544-1548.2000.
9
Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans.Etest法和Vitek 2®与肉汤微量稀释法用于新型隐球菌药敏试验的比较。
Diagn Microbiol Infect Dis. 2014 Dec;80(4):294-8. doi: 10.1016/j.diagmicrobio.2014.09.006. Epub 2014 Sep 16.
10
Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates.新型隐球菌临床分离株体外药敏试验的比浊法和视觉标准。
Mycoses. 1994 Nov-Dec;37(11-12):411-6. doi: 10.1111/j.1439-0507.1994.tb00391.x.

引用本文的文献

1
Fluconazole Resistance and Heteroresistance in Cryptococcus spp.: Mechanisms and Implications.隐球菌属中的氟康唑耐药性和异质性耐药:机制与影响
Rev Soc Bras Med Trop. 2025 Mar 24;58:e002002025. doi: 10.1590/0037-8682-0328-2024. eCollection 2025.
2
Antifungal Resistance in Cryptococcal Infections.隐球菌感染中的抗真菌耐药性
Pathogens. 2024 Jan 29;13(2):128. doi: 10.3390/pathogens13020128.
3
Methods for Antifungal Susceptibility Testing of the / Complex: Strengths and Limitations./复合体抗真菌药敏试验方法:优势与局限性
J Fungi (Basel). 2023 May 5;9(5):542. doi: 10.3390/jof9050542.
4
A Second-Generation Fungerp Analog, SCY-247, Shows Potent Activity against Candida auris and Other Clinically Relevant Fungal Isolates.第二代真菌哌仑西平类似物 SCY-247 对耳念珠菌和其他临床相关真菌分离株具有强大的活性。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.01988-20.
5
Roles for Stress Response and Cell Wall Biosynthesis Pathways in Caspofungin Tolerance in .应激反应和细胞壁生物合成途径在卡泊芬净耐受中的作用。
Genetics. 2019 Sep;213(1):213-227. doi: 10.1534/genetics.119.302290. Epub 2019 Jul 2.
6
A Systematic Screen Reveals a Diverse Collection of Medications That Induce Antifungal Resistance in Species.一项系统性筛查揭示了多种药物可诱导 种产生抗真菌耐药性。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.00054-19. Print 2019 May.
7
Physiological Differences in Cryptococcus neoformans Strains versus and Their Effects on Antifungal Susceptibility.新型隐球菌菌株的生理差异及其对抗真菌药敏性的影响
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02108-16. Print 2017 Mar.
8
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.乌干达新型隐球菌临床分离株中抗真菌药物耐药性增加。
Antimicrob Agents Chemother. 2015 Dec;59(12):7197-204. doi: 10.1128/AAC.01299-15. Epub 2015 Aug 31.
9
Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa.结节性多动脉炎患者并发新型隐球菌性脑膜脑炎
Folia Microbiol (Praha). 2014 Nov;59(6):515-21. doi: 10.1007/s12223-014-0328-0. Epub 2014 Jun 20.
10
Two Rac paralogs regulate polarized growth in the human fungal pathogen Cryptococcus neoformans.两个 Rac 同源物调控新型隐球菌的极化生长。
Fungal Genet Biol. 2013 Aug;57:58-75. doi: 10.1016/j.fgb.2013.05.006. Epub 2013 Jun 5.

本文引用的文献

1
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.乌干达艾滋病患者中新隐球菌分离株的分子流行病学及抗真菌药敏性
Diagn Microbiol Infect Dis. 1998 Nov;32(3):191-9. doi: 10.1016/s0732-8893(98)00095-9.
2
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.伏立康唑、氟康唑和伊曲康唑对来自美国和非洲的566株新生隐球菌临床分离株的体外活性。
Antimicrob Agents Chemother. 1999 Jan;43(1):169-71. doi: 10.1128/AAC.43.1.169.
3
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.美国国家临床实验室标准委员会肉汤大稀释法和琼脂稀释法对新型隐球菌氟康唑敏感性检测的比较评估
J Clin Microbiol. 1998 May;36(5):1330-2. doi: 10.1128/JCM.36.5.1330-1332.1998.
4
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.导致抗真菌药物耐药性的临床、细胞和分子因素。
Clin Microbiol Rev. 1998 Apr;11(2):382-402. doi: 10.1128/CMR.11.2.382.
5
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.伏立康唑和伊曲康唑对氟康唑敏感及耐药新生隐球菌分离株的体外比较疗效
Antimicrob Agents Chemother. 1998 Feb;42(2):471-2. doi: 10.1128/AAC.42.2.471.
6
The hidden danger of primary fluconazole prophylaxis for patients with AIDS.艾滋病患者氟康唑初级预防的隐患。
Clin Infect Dis. 1998 Jan;26(1):186-7. doi: 10.1086/517056.
7
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.抗真菌药敏试验解释性断点的制定:氟康唑、伊曲康唑和念珠菌感染的体外-体内相关性数据的概念框架与分析。美国国家临床实验室标准委员会抗真菌药敏试验小组委员会
Clin Infect Dis. 1997 Feb;24(2):235-47. doi: 10.1093/clinids/24.2.235.
8
Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients.艾滋病患者新型隐球菌分离株的电泳核型及体外抗真菌药敏性
Diagn Microbiol Infect Dis. 1995 Nov;23(3):99-103. doi: 10.1016/0732-8893(95)00169-7.
9
Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group.人类免疫缺陷病毒相关隐球菌病中新型隐球菌系列分离株的分子亚型及抗真菌药敏性。隐球菌病主动监测小组
J Infect Dis. 1996 Oct;174(4):812-20. doi: 10.1093/infdis/174.4.812.
10
Editorial response: management of cryptococcal meningitis--have we answered all the questions?编辑回应:隐球菌性脑膜炎的管理——我们是否回答了所有问题?
Clin Infect Dis. 1996 Feb;22(2):329-30. doi: 10.1093/clinids/22.2.329.

新型隐球菌的氟康唑药敏试验:两种肉汤微量稀释法的比较及乌干达艾滋病患者分离株的临床相关性

Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients.

作者信息

Jessup C J, Pfaller M A, Messer S A, Zhang J, Tumberland M, Mbidde E K, Ghannoum M A

机构信息

Mycology Reference Laboratory, Center for Medical Mycology, Department of Dermatology, Case Western Reserve University and University Hospitals of Cleveland, Ohio, USA.

出版信息

J Clin Microbiol. 1998 Oct;36(10):2874-6. doi: 10.1128/JCM.36.10.2874-2876.1998.

DOI:10.1128/JCM.36.10.2874-2876.1998
PMID:9738036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC105080/
Abstract

We compared the yeast nitrogen base (YNB) broth microdilution method with the National Committee for Clinical Laboratory Standards (NCCLS) M27-A microdilution reference method for measuring the in vitro susceptibility of Cryptococcus neoformans isolates to fluconazole. A total of 149 isolates of C. neoformans var. neoformans from Ugandan AIDS patients was tested by both methods. An overall agreement of 88% between the two microdilution methods was observed. All isolates grew well in both RPMI 1640 and YNB media, and MICs could be read after 48 h of incubation by both methods. The range of fluconazole MICs obtained with the YNB method was broader than that obtained with the NCCLS method. The extended range of MICs provided by the YNB method may be of clinical value, as it appears that the clinical outcome may be better among patients infected with strains inhibited by lower concentrations of fluconazole as determined by the YNB method. The YNB method appears to be a viable option for testing C. neoformans against fluconazole.

摘要

我们将酵母氮源基础(YNB)肉汤微量稀释法与美国国家临床实验室标准委员会(NCCLS)的M27 - A微量稀释参考方法进行了比较,以测定新型隐球菌分离株对氟康唑的体外敏感性。对来自乌干达艾滋病患者的总共149株新型隐球菌变种新型隐球菌分离株用这两种方法进行了检测。观察到两种微量稀释方法的总体符合率为88%。所有分离株在RPMI 1640和YNB培养基中均生长良好,两种方法在孵育48小时后均可读取最低抑菌浓度(MIC)。用YNB方法获得的氟康唑MIC范围比用NCCLS方法获得的范围更宽。YNB方法提供的更宽的MIC范围可能具有临床价值,因为对于感染了用YNB方法测定的对较低浓度氟康唑敏感菌株的患者,其临床结局似乎可能更好。YNB方法似乎是检测新型隐球菌对氟康唑敏感性的一个可行选择。